Adicet Bio, Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
ACET Nasdaq 2834 www.adicetbio.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Adicet Bio, Inc.

Adicet Bio Reports Second Quarter 2026 Financial Results and Provides Business Updates - Aug 5th, 2026 2:15 pm
Adicet Bio to Participate in Fireside Chat at Canaccord Genuity 46th Annual Growth Conference - Jul 21st, 2026 2:00 pm
Is Adicet Bio (ACET) Stock Outpacing Its Medical Peers This Year? - Jul 1st, 2026 7:40 am
Harbour BioMed Appoints Dr. Lloyd Klickstein as Scientific Advisor for Immunology - Jun 28th, 2026 7:27 pm
Adicet Bio Teases Autoimmune Data Catalysts, PSMA Plans at Jefferies Conference - Jun 4th, 2026 12:04 pm
Are Medical Stocks Lagging Adicet Bio (ACET) This Year? - May 28th, 2026 7:40 am
Wall Street Analysts Believe Adicet Bio (ACET) Could Rally 319.64%: Here's is How to Trade - May 25th, 2026 7:55 am
Adicet Bio (ACET) Upgraded to Buy: Here's Why - Mar 24th, 2026 10:00 am
MaxCyte Reports Third Quarter 2025 Financial Results and Reiterates Full Year 2025 Revenue Guidance - Nov 12th, 2025 2:05 pm
Are Medical Stocks Lagging Exact Sciences (EXAS) This Year? - Oct 7th, 2025 7:40 am
Adicet Bio (ACET) Upgraded to Buy: Here's What You Should Know - Sep 30th, 2025 10:00 am
MaxCyte (MXCT) Signed a Strategic Platform License with Adicet Bio - Aug 11th, 2025 7:46 am